$ARWR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in ARROWHEAD PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ARROWHEAD PHARMACEUTICALS, INC. for free.

Page:   < prev 1 2 3 4 5 5 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...Option ExerciseM5.1933,351173,092116,116
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS52.133,450179,849384,223387.7 K to 384.2 K (-0.89 %)
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS51.1110,680545,855387,673398.4 K to 387.7 K (-2.68 %)
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS49.982,800139,944398,353401.2 K to 398.4 K (-0.70 %)
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS49.0710,554517,885401,153411.7 K to 401.2 K (-2.56 %)
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS47.936,432308,286411,707418.1 K to 411.7 K (-1.54 %)
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS47.076,397301,107418,139424.5 K to 418.1 K (-1.51 %)
Jan 23 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...BuyM5.1933,351173,092424,536391.2 K to 424.5 K (+8.53 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS60.991,30079,287858,993860.3 K to 859 K (-0.15 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS60.3722,4661,356,272860,293882.8 K to 860.3 K (-2.54 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS59.5711,847705,726882,759894.6 K to 882.8 K (-1.32 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...O'Brien PatrickGeneral CounselSellS61.021006,102258,375258.5 K to 258.4 K (-0.04 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...O'Brien PatrickGeneral CounselSellS60.438,931539,700258,475267.4 K to 258.5 K (-3.34 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...O'Brien PatrickGeneral CounselSellS59.615,594333,458267,406273 K to 267.4 K (-2.05 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS60.9550030,475391,185391.7 K to 391.2 K (-0.13 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS60.4011,907719,183391,685403.6 K to 391.7 K (-2.95 %)
Jan 08 2020ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS59.607,593452,543403,592411.2 K to 403.6 K (-1.85 %)
Dec 27 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS63.5083,3335,291,6461,805,2371.9 M to 1.8 M (-4.41 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS68.183,393231,3351,888,5701.9 M to 1.9 M (-0.18 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS67.3025,4121,710,2281,891,9631.9 M to 1.9 M (-1.33 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS66.4745,5773,029,5031,917,3752 M to 1.9 M (-2.32 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS65.858,951589,4231,962,9522 M to 2 M (-0.45 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS69.418,379581,5861,971,9032 M to 2 M (-0.42 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS68.5110,343708,5991,980,2822 M to 2 M (-0.52 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS67.3158,0593,907,9511,990,6252 M to 2 M (-2.83 %)
Dec 13 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS66.8223,2191,551,4942,048,6842.1 M to 2 M (-1.12 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS62.008,022497,3642,071,9032.1 M to 2.1 M (-0.39 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS60.734,011243,5882,079,9252.1 M to 2.1 M (-0.19 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS72.953,656266,7052,083,9362.1 M to 2.1 M (-0.18 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS72.133,800274,0942,087,5922.1 M to 2.1 M (-0.18 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS70.722,448173,1232,091,3922.1 M to 2.1 M (-0.12 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS69.506,617459,8822,093,8402.1 M to 2.1 M (-0.32 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS68.508,510582,9352,100,4572.1 M to 2.1 M (-0.40 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS67.637,193486,4632,108,9672.1 M to 2.1 M (-0.34 %)
Dec 04 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS66.585,743382,3692,116,1602.1 M to 2.1 M (-0.27 %)
Nov 07 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...Option ExerciseM5.1912,64965,648149,467
Nov 07 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...BuyM5.1912,64965,648326,185313.5 K to 326.2 K (+4.03 %)
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...Option ExerciseM7.7537,884293,601162,116
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS41.2116,620684,910313,536330.2 K to 313.5 K (-5.03 %)
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS40.5621,264862,468330,156351.4 K to 330.2 K (-6.05 %)
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...BuyM7.7537,884293,601351,420313.5 K to 351.4 K (+12.08 %)
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...Option ExerciseM7.7537,884293,601162,116
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS41.2116,620684,910313,536330.2 K to 313.5 K (-5.03 %)
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS40.5621,264862,468330,156351.4 K to 330.2 K (-6.05 %)
Nov 01 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...BuyM7.7537,884293,601351,420313.5 K to 351.4 K (+12.08 %)
Oct 11 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM5.2056,325292,890945,543
Oct 11 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS31.8356,3251,792,8252,121,9032.2 M to 2.1 M (-2.59 %)
Oct 11 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM5.2056,325292,8902,178,2282.1 M to 2.2 M (+2.65 %)
Sep 27 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS28.2520,000565,0002,121,9032.1 M to 2.1 M (-0.93 %)
Sep 27 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS28.2520,000565,0002,121,9032.1 M to 2.1 M (-0.93 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM5.1066,645339,8901,001,868
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM5.1041,755212,9511,068,513
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM5.1066,645339,8901,001,868
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM5.104,25021,6751,110,268
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM5.1041,755212,9511,068,513
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS29.0412,673368,0242,141,9032.2 M to 2.1 M (-0.59 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM5.104,25021,6751,110,268
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS28.0053,9721,511,2162,154,5762.2 M to 2.2 M (-2.44 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS29.0412,673368,0242,141,9032.2 M to 2.1 M (-0.59 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM5.1066,645339,8902,208,5482.1 M to 2.2 M (+3.11 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS28.0053,9721,511,2162,154,5762.2 M to 2.2 M (-2.44 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS29.0441,7551,212,5652,141,9032.2 M to 2.1 M (-1.91 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM5.1066,645339,8902,208,5482.1 M to 2.2 M (+3.11 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM5.1041,755212,9512,183,6582.1 M to 2.2 M (+1.95 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS29.0441,7551,212,5652,141,9032.2 M to 2.1 M (-1.91 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS29.004,250123,2502,141,9032.1 M to 2.1 M (-0.20 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM5.1041,755212,9512,183,6582.1 M to 2.2 M (+1.95 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM5.104,25021,6752,146,1532.1 M to 2.1 M (+0.20 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS29.004,250123,2502,141,9032.1 M to 2.1 M (-0.20 %)
Sep 24 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM5.104,25021,6752,146,1532.1 M to 2.1 M (+0.20 %)
Sep 11 2019ARWRARROWHEAD PHARMACE ...PERRY MICHAEL SDirectorSellS30.0085,0002,550,00036,000121 K to 36 K (-70.25 %)
Sep 11 2019ARWRARROWHEAD PHARMACE ...PERRY MICHAEL SDirectorSellS28.90100,0002,890,000121,000221 K to 121 K (-45.25 %)
Jun 28 2019ARWRARROWHEAD PHARMACE ...Ferrari MauroDirectorSellS27.6117,756490,2431,90019.7 K to 1.9 K (-90.33 %)
Jun 03 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...Option ExerciseM5.1920,000103,800200,000
Jun 03 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...Option ExerciseM4.6015,00069,000220,000
Jun 03 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...BuyM5.1920,000103,800313,536293.5 K to 313.5 K (+6.81 %)
Jun 03 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...BuyM4.6015,00069,000293,536278.5 K to 293.5 K (+5.39 %)
May 29 2019ARWRARROWHEAD PHARMACE ...O'Brien PatrickGeneral CounselSellS24.8830,000746,400203,000233 K to 203 K (-12.88 %)
May 29 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM2.629,37624,5651,133,418
May 29 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...Option ExerciseM2.0140,07280,5451,142,794
May 29 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM2.629,37624,5652,141,9032.1 M to 2.1 M (+0.44 %)
May 29 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...BuyM2.0140,07280,5452,132,5272.1 M to 2.1 M (+1.92 %)
May 22 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS22.0027,071595,562278,536305.6 K to 278.5 K (-8.86 %)
Apr 05 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS19.3050,000965,0002,092,4552.1 M to 2.1 M (-2.33 %)
Mar 01 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM2.0142,50085,425350,000
Mar 01 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS19.9942,500849,575644,606687.1 K to 644.6 K (-6.19 %)
Mar 01 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM2.0142,50085,425687,106644.6 K to 687.1 K (+6.59 %)
Feb 27 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM2.0142,50085,425392,500
Feb 27 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS18.9842,500806,650644,606687.1 K to 644.6 K (-6.19 %)
Feb 27 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM2.0142,50085,425687,106644.6 K to 687.1 K (+6.59 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM4.757,00033,2500
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM2.6210,00026,2007,000
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM2.1918,00039,42017,000
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM5.1930,000155,70035,000
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS19.2565,0001,251,250175,130240.1 K to 175.1 K (-27.07 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM4.757,00033,250240,130233.1 K to 240.1 K (+3.00 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM2.6210,00026,200233,130223.1 K to 233.1 K (+4.48 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM2.1918,00039,420223,130205.1 K to 223.1 K (+8.77 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM5.1930,000155,700205,130175.1 K to 205.1 K (+17.13 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS18.053,00054,150175,130178.1 K to 175.1 K (-1.68 %)
Feb 20 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...Option ExerciseM5.208,00041,600235,000
Feb 20 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS18.008,000144,000305,607313.6 K to 305.6 K (-2.55 %)
Feb 20 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...BuyM5.208,00041,600313,607305.6 K to 313.6 K (+2.62 %)
Feb 20 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM2.0142,50085,425435,000
Feb 20 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS17.9842,500764,150644,606687.1 K to 644.6 K (-6.19 %)
Feb 20 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM2.0142,50085,425687,106644.6 K to 687.1 K (+6.59 %)
Feb 20 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS17.6726,250463,838644,606670.9 K to 644.6 K (-3.91 %)
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM2.0142,50085,425477,500
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM2.6211,66730,568520,000
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM2.6211,66730,568531,667
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS17.0642,500725,050670,856713.4 K to 670.9 K (-5.96 %)
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM2.0142,50085,425713,356670.9 K to 713.4 K (+6.34 %)
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS16.4857,000939,360670,856727.9 K to 670.9 K (-7.83 %)
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS15.6697,1671,521,635727,856825 K to 727.9 K (-11.78 %)
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM2.6211,66730,568825,023813.4 K to 825 K (+1.43 %)
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS15.3446,167708,202813,356859.5 K to 813.4 K (-5.37 %)
Feb 12 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM2.6211,66730,568859,523847.9 K to 859.5 K (+1.38 %)
Feb 07 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS14.4822,500325,800847,856870.4 K to 847.9 K (-2.59 %)
Feb 01 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS13.8528,500394,725870,356898.9 K to 870.4 K (-3.17 %)
Jan 24 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS13.1517,500230,125898,856916.4 K to 898.9 K (-1.91 %)
Jan 24 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS13.59152,0002,065,680916,3561.1 M to 916.4 K (-14.23 %)
Jan 24 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS13.583,00040,740178,130181.1 K to 178.1 K (-1.66 %)
Jan 18 2019ARWRARROWHEAD PHARMACE ...O'Brien PatrickGeneral CounselSellS14.4372,0001,038,960233,000305 K to 233 K (-23.61 %)
Jan 18 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS14.5581,8751,191,281305,607387.5 K to 305.6 K (-21.13 %)
Jan 16 2019ARWRARROWHEAD PHARMACE ...Li ZhenSnr. VP, Chem and N ...SellS14.3440,500580,770201,700242.2 K to 201.7 K (-16.72 %)
Jan 16 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM6.201,0006,200543,334
Jan 16 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...Option ExerciseM2.6211,66630,565544,334
Jan 16 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS14.4042,666614,3901,068,3561.1 M to 1.1 M (-3.84 %)
Jan 16 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM6.201,0006,2001,111,0221.1 M to 1.1 M (+0.09 %)
Jan 16 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...BuyM2.6211,66630,5651,110,0221.1 M to 1.1 M (+1.06 %)
Jan 11 2019ARWRARROWHEAD PHARMACE ...Waddill William D.DirectorSellS14.778,500125,54546,50055 K to 46.5 K (-15.45 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...Waddill William D.DirectorGrantA0.0030,000055,00025 K to 55 K (+120.00 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...Ferrari MauroDirectorGrantA0.003,429019,65616.2 K to 19.7 K (+21.13 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...PERRY MICHAEL SDirectorGrantA0.0036,0000221,000185 K to 221 K (+19.46 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGrantA0.0036,0000181,130145.1 K to 181.1 K (+24.81 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...Li ZhenSnr. VP, Chem and N ...GrantA0.0075,0000242,200167.2 K to 242.2 K (+44.86 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...O'Brien PatrickGeneral CounselGrantA0.0070,0000305,000235 K to 305 K (+29.79 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...SellS11.988,33399,829387,482395.8 K to 387.5 K (-2.11 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...Myszkowski Kenneth AllenChief Financial Off ...GrantA0.0085,0000395,815310.8 K to 395.8 K (+27.35 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...SellS11.9820,000239,6001,098,3561.1 M to 1.1 M (-1.79 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...GIVEN BRUCE DChief Operating Off ...GrantA0.00210,00001,118,356908.4 K to 1.1 M (+23.12 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...GrantA0.00600,00002,142,4551.5 M to 2.1 M (+38.90 %)
Dec 28 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS12.003,00036,000145,130148.1 K to 145.1 K (-2.03 %)
Dec 21 2018ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS13.9290,0001,252,8001,542,4551.6 M to 1.5 M (-5.51 %)
Dec 19 2018ARWRARROWHEAD PHARMACE ...Ferrari MauroDirectorGrantA0.003,459016,22712.8 K to 16.2 K (+27.09 %)
Dec 19 2018ARWRARROWHEAD PHARMACE ...Ferrari MauroDirectorGrantA0.003,459016,22712.8 K to 16.2 K (+27.09 %)
Dec 14 2018ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS14.0790,0001,266,3001,632,4551.7 M to 1.6 M (-5.23 %)
Nov 26 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS12.743,00038,220148,130151.1 K to 148.1 K (-1.99 %)
Nov 26 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS12.743,00038,220148,130151.1 K to 148.1 K (-1.99 %)
Nov 09 2018ARWRARROWHEAD PHARMACE ...Anzalone Christopher RichardChief Executive Off ...SellS14.955,30079,2351,722,4551.7 M to 1.7 M (-0.31 %)

Page:   < prev 1 2 3 4 5 5 next >

Contact us | Follow us on Twitter